By Deena Beasley and Julie Steenhuysen (Reuters) - In approving the first new Alzheimer's drug in nearly 20 years, the U.S. Food and Drug Administrati.
Biogen reports new data backing long-term benefit of Spinraza pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
Analysis: U S FDA faces mounting criticism over Alzheimer s drug approval netscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from netscape.com Daily Mail and Mail on Sunday newspapers.
The drug was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer's, rather than proof that it slows progression of the disease.
By Deena Beasley and Julie Steenhuysen (Reuters) - In approving the first new Alzheimer's drug in nearly 20 years, the U.S. Food and Drug Administrati.